![]() SiteOne Therapeutics SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders. | ![]() Inflazome Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome. | ||
Founding Date | Founding Date 2014 | Founding Date 2016 | Founding Date 1990 |
Type | Type Private | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations San Francisco, US HQ Bozeman, US | Locations Dublin 2, IE HQ Brisbane City, AU Cambridge, GB | Locations Ewing Township, US HQ |
Employees | Employees 2216% increase | Employees 156% decrease | Employees 4 |
Funding | |||
Total funding raised | Total funding raised $ 17.8m | Total funding raised $ 17m | Total funding raised N/A |

Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome.
View companyCellOxess is a company that provides healthcare and biotechnology services.
View company